12/09/2025
ANAPHYLAXIS UPDATE
MHRA approves needle-free Adrenaline nasal spray.
Follow the link to find out more.
If these devices are brought into your setting, some update training may be required for your staff. Please contact me for more details.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 18 July 2025, approved adrenaline (epinephrine) nasal spray (EURneffy) to be used for the emergency treatment of serious allergic reactions, known as anaphylaxis.